Literature DB >> 34976371

Extracorporeal Liver Support: A Bridge to Somewhere.

Abraham J Matar1, Ram Subramanian2,3.   

Abstract

Content available: Audio Recording.
© 2021 by the American Association for the Study of Liver Diseases.

Entities:  

Year:  2021        PMID： 34976371      PMCID： PMC8688900          DOI： 10.1002/cld.1140

Source DB:  PubMed          Journal:  Clin Liver Dis (Hoboken)        ISSN： 2046-2484


  17 in total

1.  Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute-on-chronic liver failure.

Authors:  L E Schmidt; V R Sørensen; L B Svendsen; B A Hansen; F S Larsen
Journal:  Liver Transpl       Date:  2001-12       Impact factor: 5.799

2.  Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial.

Authors:  Lars E Schmidt; Lars Peter Wang; Bent A Hansen; Fin Stolze Larsen
Journal:  Liver Transpl       Date:  2003-03       Impact factor: 5.799

3.  Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial.

Authors:  Faouzi Saliba; Christophe Camus; François Durand; Philippe Mathurin; Alexia Letierce; Bertrand Delafosse; Karl Barange; Pierre François Perrigault; Magali Belnard; Philippe Ichaï; Didier Samuel
Journal:  Ann Intern Med       Date:  2013-10-15       Impact factor: 25.391

4.  Molecular Adsorbent Recirculating System Effectively Replaces Hepatic Function in Severe Acute Liver Failure.

Authors:  Steven I Hanish; Deborah M Stein; Joseph R Scalea; Eno-Obong Essien; Paul Thurman; William R Hutson; Stephen T Bartlett; Rolf N Barth; Thomas M Scalea
Journal:  Ann Surg       Date:  2017-10       Impact factor: 12.969

5.  Pathophysiological effects of albumin dialysis in acute-on-chronic liver failure: a randomized controlled study.

Authors:  Sambit Sen; Nathan A Davies; Rajeshwar P Mookerjee; Lisa M Cheshire; Stephen J Hodges; Roger Williams; Rajiv Jalan
Journal:  Liver Transpl       Date:  2004-09       Impact factor: 5.799

6.  First use of the Molecular Adsorbent Recirculating System technique on patients with hypoxic liver failure after cardiogenic shock.

Authors:  A El Banayosy; L Kizner; V Schueler; S Bergmeier; D Cobaugh; R Koerfer
Journal:  ASAIO J       Date:  2004 Jul-Aug       Impact factor: 2.872

7.  Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials.

Authors:  Fayez Alshamsi; Khalil Alshammari; Emilie Belley-Cote; Joanna Dionne; Talal Albrahim; Budoor Albudoor; Mona Ismail; Bandar Al-Judaibi; Bandar Baw; Ram M Subramanian; Randolph Steadman; Dragos Galusca; David T Huang; Rahul Nanchal; Mustafa Al Quraini; Yuhong Yuan; Waleed Alhazzani
Journal:  Intensive Care Med       Date:  2019-10-07       Impact factor: 17.440

8.  Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure.

Authors:  Wim Laleman; Alexander Wilmer; Pieter Evenepoel; Ingrid Vander Elst; Marcel Zeegers; Zahur Zaman; Chris Verslype; Johan Fevery; Frederik Nevens
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

9.  High-volume plasma exchange in patients with acute liver failure: An open randomised controlled trial.

Authors:  Fin Stolze Larsen; Lars Ebbe Schmidt; Christine Bernsmeier; Allan Rasmussen; Helena Isoniemi; Vishal C Patel; Evangelos Triantafyllou; William Bernal; Georg Auzinger; Debbie Shawcross; Martin Eefsen; Peter Nissen Bjerring; Jens Otto Clemmesen; Krister Hockerstedt; Hans-Jørgen Frederiksen; Bent Adel Hansen; Charalambos G Antoniades; Julia Wendon
Journal:  J Hepatol       Date:  2015-08-29       Impact factor: 25.083

10.  Extracorporeal liver support: a continuing challenge.

Authors:  Ram M Subramanian; John A Kellum
Journal:  Crit Care       Date:  2007       Impact factor: 9.097
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.